Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roger Douglas Weiss, M.D.

Co-Author

This page shows the publications co-authored by Roger Weiss and Rebecca McHugh.
Connection Strength

18.227
  1. Are Pain and Negative Affect Coping Distinct Motives for Opioid Misuse? Subst Use Misuse. 2022; 57(6):848-852.
    View in: PubMed
    Score: 0.991
  2. Do people with opioid use disorder and posttraumatic stress disorder benefit from dding Individual opioid Drug Counseling to buprenorphine? Drug Alcohol Depend. 2021 11 01; 228:109084.
    View in: PubMed
    Score: 0.960
  3. Validation of the craving scale in a large sample of adults with substance use disorders. Addict Behav. 2021 02; 113:106651.
    View in: PubMed
    Score: 0.898
  4. Sex differences in benzodiazepine misuse among adults with substance use disorders. Addict Behav. 2021 01; 112:106608.
    View in: PubMed
    Score: 0.889
  5. Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use. J Subst Abuse Treat. 2020 10; 117:108061.
    View in: PubMed
    Score: 0.880
  6. Clinical Correlates of Smoking Status in Men and Women with Opioid Use Disorder. Subst Use Misuse. 2020; 55(7):1054-1058.
    View in: PubMed
    Score: 0.858
  7. Pain catastrophizing and distress intolerance: prediction of pain and emotional stress reactivity. J Behav Med. 2020 08; 43(4):623-629.
    View in: PubMed
    Score: 0.828
  8. Alcohol Use Disorder and Depressive Disorders. Alcohol Res. 2019 10 21; 40(1).
    View in: PubMed
    Score: 0.795
  9. Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use. Am J Addict. 2018 09; 27(6):485-490.
    View in: PubMed
    Score: 0.770
  10. Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods. Contemp Clin Trials. 2017 09; 60:105-112.
    View in: PubMed
    Score: 0.717
  11. Perceived barriers to smoking cessation among adults with substance use disorders. J Subst Abuse Treat. 2017 03; 74:48-53.
    View in: PubMed
    Score: 0.692
  12. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addict Behav. 2017 02; 65:283-288.
    View in: PubMed
    Score: 0.674
  13. Association between a brief alcohol craving measure and drinking in the following week. Addiction. 2016 06; 111(6):1004-10.
    View in: PubMed
    Score: 0.655
  14. Cue-induced craving to paraphernalia and drug images in opioid dependence. Am J Addict. 2016 Mar; 25(2):105-9.
    View in: PubMed
    Score: 0.650
  15. Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug Alcohol Depend. 2014 Dec 01; 145:121-6.
    View in: PubMed
    Score: 0.594
  16. Prescription drug abuse: from epidemiology to public policy. J Subst Abuse Treat. 2015 Jan; 48(1):1-7.
    View in: PubMed
    Score: 0.588
  17. Cue-induced craving in dependence upon prescription opioids and heroin. Am J Addict. 2014 Sep-Oct; 23(5):453-8.
    View in: PubMed
    Score: 0.570
  18. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013 Jul; 45(1):38-43.
    View in: PubMed
    Score: 0.525
  19. Positive affect and stress reactivity in alcohol-dependent outpatients. J Stud Alcohol Drugs. 2013 Jan; 74(1):152-7.
    View in: PubMed
    Score: 0.524
  20. Clinical utility of a hybrid secondary and relapse prevention program in adults with mild intellectual disability or borderline intellectual functioning in community residential and day habilitation settings. Disabil Health J. 2022 Feb 26; 101293.
    View in: PubMed
    Score: 0.247
  21. Psychometric properties of the Anxiety Sensitivity Index-3 in adults with substance use disorders. J Subst Abuse Treat. 2022 01; 132:108507.
    View in: PubMed
    Score: 0.235
  22. Associations between Childhood Abuse and Chronic Pain in Adults with Substance Use Disorders. Subst Use Misuse. 2021; 56(1):87-92.
    View in: PubMed
    Score: 0.226
  23. Pain interference and catastrophizing are not associated with polysubstance use among treatment-seeking patients with substance use disorders and chronic pain. Am J Drug Alcohol Abuse. 2020 09 02; 46(5):604-612.
    View in: PubMed
    Score: 0.220
  24. Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder. Drug Alcohol Depend. 2020 Jun 12; 213:108122.
    View in: PubMed
    Score: 0.220
  25. Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder. Drug Alcohol Depend. 2019 12 01; 205:107675.
    View in: PubMed
    Score: 0.210
  26. Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders. Drug Alcohol Depend. 2019 12 01; 205:107644.
    View in: PubMed
    Score: 0.210
  27. Associations between pain catastrophizing and clinical characteristics in adults with substance use disorders and co-occurring chronic pain. Am J Drug Alcohol Abuse. 2019; 45(5):488-494.
    View in: PubMed
    Score: 0.203
  28. Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence. J Clin Psychiatry. 2019 03 26; 80(2).
    View in: PubMed
    Score: 0.202
  29. Religious coping in patients with severe substance use disorders receiving acute inpatient detoxification. Am J Addict. 2017 Oct; 26(7):744-750.
    View in: PubMed
    Score: 0.181
  30. Grit in patients with substance use disorders. Am J Addict. 2016 Dec; 25(8):652-658.
    View in: PubMed
    Score: 0.171
  31. Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users. Drug Alcohol Depend. 2016 Dec 01; 169:68-72.
    View in: PubMed
    Score: 0.171
  32. Prevalence of restless legs syndrome during detoxification from alcohol and opioids. J Subst Abuse Treat. 2017 02; 73:35-39.
    View in: PubMed
    Score: 0.170
  33. Perceived risk of heroin use among nonmedical prescription opioid users. Addict Behav. 2017 02; 65:218-223.
    View in: PubMed
    Score: 0.168
  34. Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug Alcohol Depend. 2016 Jun 01; 163:216-21.
    View in: PubMed
    Score: 0.165
  35. Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain. J Pain. 2016 07; 17(7):806-14.
    View in: PubMed
    Score: 0.164
  36. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend. 2015 May 01; 150:112-9.
    View in: PubMed
    Score: 0.152
  37. Denial of urinalysis-confirmed opioid use in prescription opioid dependence. J Subst Abuse Treat. 2015 Jan; 48(1):85-90.
    View in: PubMed
    Score: 0.146
  38. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abuse Treat. 2014 Aug; 47(2):140-5.
    View in: PubMed
    Score: 0.143
  39. Readability of self-report alcohol misuse measures. J Stud Alcohol Drugs. 2014 Mar; 75(2):328-34.
    View in: PubMed
    Score: 0.142
  40. Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2014 Feb; 27(1):82-9.
    View in: PubMed
    Score: 0.141
  41. The Opioid Use Disorder Core Outcomes Set (OUD-COS) for treatment research: findings from a Delphi consensus study. Addiction. 2022 Mar 16.
    View in: PubMed
    Score: 0.062
  42. Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic. Am J Addict. 2021 09; 30(5):445-452.
    View in: PubMed
    Score: 0.060
  43. Tobacco Use Predicts Treatment Dropout and Outcome in an Acute, Transdiagnostic Psychiatric Treatment Setting. Behav Ther. 2021 07; 52(4):897-906.
    View in: PubMed
    Score: 0.057
  44. Anxiety sensitivity and grit as mediators between childhood abuse and relapse risk for substance use. Child Abuse Negl. 2020 09; 107:104568.
    View in: PubMed
    Score: 0.055
  45. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. Drug Alcohol Depend. 2018 08 01; 189:96-107.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.